Altium Capital Management LP Infinity Pharmaceuticals, Inc. Transaction History

Altium Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $1.42 Million - $3.57 Million	-934,327 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$2.66 - $3.47 $101,080 - $131,860	-38,000 Reduced 3.91%	934,327 $2.79 Million
Q1 2021 May 06, 2021	BUY	$1.98 - $5.36 $1.93 Million - $5.21 Million	972,327 New	972,327 $3.14 Million

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.